ALB and Sepsis: However, in the ALBIOS trial, Caironi et al. analyzed 1818 patients with severe sepsis in the ICU and reported that albumin replacement did not improve 28- and 90-day survival rates, although the patients who underwent albumin replacement exhibited high serum albumin levels, high mean arterial pressure, and low net fluid balance [12].